Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer.
about
Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literatureAn overview of long non-coding RNAs in ovarian cancersLong noncoding RNAs in gastric cancer: functions and clinical applicationsMolecular mechanisms of long noncoding RNAs on gastric cancerEmerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implicationsCompeting endogenous RNA networks and gastric cancerDysregulation of non-coding RNAs in gastric cancerLong non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translationEpigenetic roles in the malignant transformation of gastric mucosal cellsLong Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?Novel genes associated with lymph node metastasis in triple negative breast cancerThe Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung AdenocarcinomaExpression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb PathwayGastric Cancer in the Era of Precision Medicine.Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer.Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3.Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression.LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation.Emerging paradigms of long non-coding RNAs in gastrointestinal cancer.Enhanced expression of long noncoding RNA CARLo-5 is associated with the development of gastric cancerConcomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinomaIncreased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancerCharacterization of differentially expressed genes involved in pathways associated with gastric cancer.Roles of long non-coding RNAs in gastric cancer metastasisLong noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysisTumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.LncRNAs: From Basic Research to Medical ApplicationSilencing of MAP4K4 by short hairpin RNA suppresses proliferation, induces G1 cell cycle arrest and induces apoptosis in gastric cancer cells.Down regulated lncRNA MEG3 eliminates mycobacteria in macrophages via autophagyDistinct Profiles for Mitochondrial t-RNAs and Small Nucleolar RNAs in Locally Invasive and Metastatic Colorectal Cancer.Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer.Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expressionCrosstalk between Meg3 and miR-1297 regulates growth of testicular germ cell tumor through PTEN/PI3K/AKT pathway.Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancerSIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patientsOver-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE.Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer.LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer.
P2860
Q26741242-7992C0A6-9DC7-484B-8312-EBF8617B7239Q26753467-40670B57-946B-4980-B1CD-85BC140B407AQ26765291-C2E8BD0B-A6C4-4B33-9BE9-08500967ED4CQ26770685-B1D3AFE1-C013-4A3E-A3E5-BDFAEE8074D7Q26774498-2C91AB66-B56C-4D2E-A111-AE635328B0E4Q26778019-35F418E8-6037-4F50-99B3-FE43E4401B0FQ26780293-4969D6DE-09D4-4C9D-BCFE-EC0A66526FEDQ26996377-9A3D0009-9379-429E-8ECD-C5636A7AA380Q28070086-8140706A-964B-425D-8071-495D8ABF5E03Q28088454-7E90BC1C-D5EC-4DCD-AE14-74CF28109761Q28393204-3611FB61-3FE8-44BB-82A6-BC69876A8A1BQ28547372-11F66109-2FF7-4B26-8363-E78A87B6E8F9Q28553467-92DF44A8-1757-4DC5-A55C-83A5D0347BCCQ33600457-66351C43-CB68-4C7C-9037-DF0C3794F1AEQ33604323-20D9FA72-ED15-48E4-AC66-47311E2668A0Q33761884-A1FB1C3B-550F-443A-8276-72E48F9E4B13Q33888751-1FF9455B-40C1-4B06-A85C-0D91481D978DQ33926034-0A1A4170-C19E-4F3F-8D65-694BBD322FF3Q34178419-3255E030-7844-42FC-A376-D8973788704CQ34462350-8A4E0AA7-9EBB-4FF9-B043-4211349EB457Q35142587-BB556BF5-182D-442E-89D9-9559CA0F6BD2Q35406622-F30D309B-7EAA-4EF0-9F59-7343884DD3A5Q35557670-8D8D7D60-6214-4210-AD52-987822E4522AQ35567632-4D3E7C0E-8263-4315-A49C-CD9241329EA7Q36095051-C83DCF6D-C12C-414C-8D16-7B65919D4F6DQ36161900-5F6961A6-C058-41D6-9193-C600999E1E7CQ36331304-61714522-1247-4BE7-A910-609E1AE2FE78Q36390246-7C34DA7B-C21D-4A21-A703-AEC05C0467AEQ36499296-AEDC22B4-9FE0-4BBE-B2FE-EBAAF7410B14Q36535386-F467130A-DFAF-423B-ABF1-8382005B075AQ36547631-1126B141-C992-4CCD-84D1-8CF6CD4A71DCQ36722246-38CEF493-E24C-482F-BC75-2B4B9900B172Q36841340-84F51686-B16B-4EED-9843-04D20E817B8FQ36843820-BE482894-773F-4602-8B77-8C40B9FA9F39Q37094937-45574209-0B3F-435F-A1CC-B8DE7E95ECE3Q37109899-406D8EDB-627A-4AC3-838F-8805376AD46AQ37285274-B636E637-A2AA-49F9-A653-D6ED4EDC0CF0Q37336665-F9148BA1-4EAB-4D3F-B185-13446433CB72Q37375136-E049AE77-AE43-4C45-9A7D-192176B4967AQ37448235-A7368232-9C6D-4252-B56C-00D9FA98E7C7
P2860
Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Downregulated long noncoding R ...... oliferation in gastric cancer.
@en
Downregulated long noncoding R ...... oliferation in gastric cancer.
@nl
type
label
Downregulated long noncoding R ...... oliferation in gastric cancer.
@en
Downregulated long noncoding R ...... oliferation in gastric cancer.
@nl
prefLabel
Downregulated long noncoding R ...... oliferation in gastric cancer.
@en
Downregulated long noncoding R ...... oliferation in gastric cancer.
@nl
P2093
P2860
P1433
P1476
Downregulated long noncoding R ...... oliferation in gastric cancer.
@en
P2093
Feiyan Jin
Tongpeng Xu
Xianghua Liu
Zhijun Liu
P2860
P2888
P304
P356
10.1007/S13277-013-1142-Z
P577
2013-09-05T00:00:00Z
P6179
1003630716